Analysts Arthur Wong and Adam Dibe discuss pharma trying to improve their public image, pharma pricing and transparency, Merck’s disclosing their gross and net pricing, and Johnson & Johnson’s acquisition of Actelion.

Analysts Arthur Wong and Adam Dibe discuss pharma trying to improve their public image, pharma pricing and transparency, Merck’s disclosing their gross and net pricing, and Johnson &amp; Johnson’s acquisition of Actelion.

The S&P Pharma Dose - Episode 12: Pharma Chat –  It’s All in the Transparency

S&P Global Ratings Podcast. Tune in for S&P Global Ratings analysts' opinions on trends and events that affect the global markets and your investment decisions. Download the S&P Global Ratings' Podcast to any portable audio device or your desktop. Make the most of your time and stay on top of important business developments around the world. Listen in! Our CreditMatters videos and podcasts provide an easy and informative way to keep up with S&P Global Ratings' global perspective on important credit market developments anytime, anywhere.

Business

S&amp;P Global Ratings Podcast. Tune in for S&amp;P Global Ratings analysts' opinions on trends and events that affect the global markets and your investment decisions. Download the S&amp;P Global Ratings' Podcast to any portable audio device or your desktop. Make the most of your time and stay on top of important business developments around the world. Listen in! Our CreditMatters videos and podcasts provide an easy and informative way to keep up with S&amp;P Global Ratings' global perspective on important credit market developments anytime, anywhere.

Share The S&P Pharma Dose - Episode 12: Pharma Chat – It’s All in the Transparency

Sign up to save your podcasts

The S&P Pharma Dose - Episode 12: Pharma Chat – It’s All in the Transparency

The S&P Pharma Dose - Episode 12: Pharma Chat – It’s All in the Transparency